TLR4 Activates the β-catenin Pathway to Cause Intestinal Neoplasia

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Santaolalla, Rebeca ^a   Sussman, Daniel A ^a   Ruiz, Jose R ^a   Davies, Julie M ^a   Pastorini, Cristhine ^a   España, Cecilia L ^a   Sotolongo, John ^a   Burlingame, Oname ^a   Bejarano, Pablo A ^a   Philip, Sakhi ^b   Ahmed, Mansoor M ^b   Ko, Jeffrey ^c   Dirisina, Ramanarao ^c   Barrett, Terrence A ^c   Shang, Limin ^d   Lira, Sergio A ^d   Fukata, Masayuki ^a   Abreu, Maria T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; PHOSPHATIDYLINOSITOL 3 KINASE; TOLL LIKE RECEPTOR 4; TUMOR PROMOTER; VILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL EXPANSION; CELL PROLIFERATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DUODENUM DISEASE; DYSPLASIA; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOSTIMULATION; INNATE IMMUNITY; INTESTINE CRYPT; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN PHOSPHORYLATION; WNT SIGNALING PATHWAY;

ADENOMA; ANIMALS; CARCINOGENESIS; COLORECTAL NEOPLASMS; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; MICE; MICROFILAMENT PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84877753124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063298     Document Type: Article

References (67)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IRC CancerBase No.10 [Internet]. Lyon, France: International Agency for Research on Cancer.
3. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, et al. (2012) Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths. New England Journal of Medicine 366: 687-696.
4. Arber N, Eagle CJ, Spicak J, Racz I, Dite P, et al. (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355: 885-895.
5. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, et al. (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355: 873-884.
6. Ullman TA, Itzkowitz SH, (2011) Intestinal inflammation and cancer. Gastroenterology 140: 1807-1816.
7. Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, et al. (2011) Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis 17: 1464-1473.
8. Sekirov I, Russell SL, Antunes LCM, Finlay BB, (2010) Gut Microbiota in Health and Disease. Physiological Reviews 90: 859-904.
9. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, et al. (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133: 1869-1881.
10. Eyking A, Ey B, Runzi M, Roig AI, Reis H, et al. (2011) Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon Cancer. Gastroenterology.
11. Slattery ML, Herrick JS, Bondurant KL, Wolff RK (2011) Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. International journal of cancer Journal international du cancer.
12. Cammarota R, Bertolini V, Pennesi G, Bucci EO, Gottardi O, et al. (2010) The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. J Transl Med 8: 112.
13. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, et al. (2010) High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 102: 908-915.
14. Earl TM, Nicoud IB, Pierce JM, Wright JP, Majoras NE, et al. (2009) Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis. Ann Surg Oncol 16: 1043-1050.
15. Segditsas S, Tomlinson I, (2006) Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537.
16. Abdul Khalek FJ, Gallicano GI, Mishra L (2010) Colon cancer stem cells. Gastrointestinal cancer research: GCR: S16-23.
17. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790.
18. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, et al. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
19. Sun J, (2010) Enteric Bacteria and Cancer Stem Cells. Cancers (Basel) 3: 285-297.
20. Valenta T, Hausmann G, Basler K, (2012) The many faces and functions of [beta]-catenin. EMBO J 31: 2714-2736.
21. Shang L, Fukata M, Thirunarayanan N, Martin AP, Arnaboldi P, et al. (2008) Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135: 529-538.
22. Lee G, Goretsky T, Managlia E, Dirisina R, Singh AP, et al. (2010) Phosphoinositide 3-Kinase Signaling Mediates [beta]-Catenin Activation in Intestinal Epithelial Stem and Progenitor Cells in Colitis. Gastroenterology 139: 869-881.e869.
23. Abreu MT, (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10: 131-144.
24. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, et al. (2001) Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609-1616.
25. Otte JM, Cario E, Podolsky DK, (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054-1070.
26. Pinto D, Robine S, Jaisser Fdr, Marjou FE, Louvard D, (1999) Regulatory Sequences of the Mouse Villin Gene That Efficiently Drive Transgenic Expression in Immature and Differentiated Epithelial Cells of Small and Large Intestines. Journal of Biological Chemistry 274: 6476-6482.
27. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007.
28. Neufert C, Becker C, Neurath MF, (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protocols 2: 1998-2004.
29. Bennecke M, Kriegl L, Bajbouj M, Retzlaff K, Robine S, et al. (2010) Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal Tumorigenesis. Cancer Cell 18: 135-146.
30. Meunier C, Cai J, Fortin A, Kwan T, Marquis JF, et al. (2009) Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3. Oncogene 29: 647-661.
31. Bissahoyo A, Pearsall RS, Hanlon K, Amann V, Hicks D, et al. (2005) Azoxymethane Is a Genetic Background-Dependent Colorectal Tumor Initiator and Promoter in Mice: Effects of Dose, Route, and Diet. Toxicological Sciences 88: 340-345.
32. Fan X-S, Wu H-Y, Yu H-P, Zhou Q, Zhang Y-F, et al. (2010) Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. International Journal of Colorectal Disease 25: 583-590.
33. Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, et al (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562-4569.
34. Fogh J, Fogh JM, Orfeo T, (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226.
35. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669.
36. Quaroni A, Wands J, Trelstad RL, Isselbacher KJ, (1979) Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80: 248-265.
37. Soubeyran P, Haglund K, Garcia S, Barth BU, Iovanna J, et al. (2001) Homeobox gene Cdx1 regulates Ras, Rho and PI3 kinase pathways leading to transformation and tumorigenesis of intestinal epithelial cells. Oncogene 20: 4180-4187.
38. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, et al. (2006) Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877.
39. Hsu D, Fukata M, Hernandez YG, Sotolongo JP, Goo T, et al. (2010) Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Lab Invest.
40. Miller JR, Moon RT, (1997) Analysis of the signaling activities of localization mutants of beta-catenin during axis specification in Xenopus. J Cell Biol 139: 229-243.
41. Mao B, Wu W, Li Y, Hoppe D, Stannek P, et al. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411: 321-325.
42. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA, (2001) Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 3: 683-686.
43. Semenov MV, Tamai K, Brott BK, Kuhl M, Sokol S, et al. (2001) Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11: 951-961.
44. Kaler P, Augenlicht L, Klampfer L, (2009) Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 28: 3892-3902.
45. Kaler P, Godasi BN, Augenlicht L, Klampfer L (2009) The NF-kappaB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1beta. Cancer Microenviron.
46. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R, (1997) [beta]-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
47. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, et al. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736.
48. Burgering BM, Coffer PJ, (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
49. Kohn AD, Kovacina KS, Roth RA, (1995) Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 14: 4288-4295.
50. Monick MM, Carter AB, Robeff PK, Flaherty DM, Peterson MW, et al. (2001) Lipopolysaccharide Activates Akt in Human Alveolar Macrophages Resulting in Nuclear Accumulation and Transcriptional Activity of Î2-Catenin. The Journal of Immunology 166: 4713-4720.
51. Hsu RYC, Chan CHF, Spicer JD, Rousseau MC, Giannias B, et al. (2011) LPS-Induced TLR4 Signaling in Human Colorectal Cancer Cells Increases Beta1-Integrin-Mediated Cell Adhesion and Liver Metastasis. Cancer Research 71: 1989-1998.
52. Laird MHW, Rhee SH, Perkins DJ, Medvedev AE, Piao W, et al. (2009) TLR4/MyD88/PI3K interactions regulate TLR4 signaling. Journal of Leukocyte Biology 85: 966-977.
53. Brown JB, Cheresh P, Goretsky T, Managlia E, Grimm GR, et al. (2011) Epithelial Phosphatidylinositol-3-Kinase Signaling Is Required for {beta}-Catenin Activation and Host Defense against Citrobacter rodentium Infection. Infect Immun 79: 1863-1872.
54. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
55. Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T, et al. (2011) Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res 31: 263-270.
56. Ramanathan V, Jin G, Westphalen CB, Whelan A, Dubeykovskiy A, et al. (2012) P53 Gene Mutation Increases Progastrin Dependent Colonic Proliferation and Colon Cancer Formation in Mice. Cancer Invest.
57. Neal MD, Sodhi CP, Jia H, Dyer M, Egan CE, et al. (2012) Toll-like Receptor 4 Is Expressed on Intestinal Stem Cells and Regulates Their Proliferation and Apoptosis via the p53 Up-regulated Modulator of Apoptosis. Journal of Biological Chemistry 287: 37296-37308.
58. Ihle NT, Powis G, Kopetz S, (2011) PI-3-Kinase inhibitors in colorectal cancer. Curr Cancer Drug Targets 11: 190-198.
59. Hu T, Li C, (2010) Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer 9: 236.
60. Hoschuetzky H, Aberle H, Kemler R, (1994) Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 127: 1375-1380.
61. Hernandez Y, Sotolongo J, Breglio K, Conduah D, Chen A, et al. (2010) The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia. BMC Gastroenterol 10: 82.
62. Lee SH, Hu L-L, Gonzalez-Navajas J, Seo GS, Shen C, et al. (2010) ERK activation drives intestinal tumorigenesis in Apcmin/+ mice. Nat Med 16: 665-670.
63. Rakoff-Nahoum S, Medzhitov R, (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124-127.
64. Huang B, Zhao J, Li H, He KL, Chen Y, et al. (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65: 5009-5014.
65. Sodhi CP, Shi XH, Richardson WM, Grant ZS, Shapiro RA, et al. (2010) Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 138: 185-196.
66. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, et al. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288: G1055-1065.
67. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R, (2004) Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis. Cell 118: 229-241.